Categories: BioTechDeliveryDevelopmentDrugPlatformTechnology
i2o Therapeutics is a Boston-based biotech startup delivering biologics orally.
Investors 2
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.04.2020 | Seed | $4M | - |
Mentions in press and media 6
| Date | Title | Description |
| 12.04.2020 | Harvard-launched biotech startup i2O Therapeutics launches to replace syringes with pills for oral delivery of many injectable drugs, including insulin | i2o Therapeutics, a Boston, MA-based biotech startup developing a platform for oral delivery of traditionally injectable biological drugs, has launched to commercialize innovations developed at Harvard University that may one day enable pat... |
| 09.04.2020 | i2O Therapeutics Raises $4M In Seed Funding | BOSTON--(BUSINESS WIRE)--i2O Therapeutics, an innovative biotech company developing a platform for oral delivery of traditionally injectable biological drugs, announced today it has raised a $4 million seed funding round led by Sanofi Ventu... |
| 09.04.2020 | i2O Therapeutics Raises $4m in Seed Funding | i2O Therapeutics, a Boston, MA-based biotech company developing a platform for oral delivery of traditionally injectable biological drugs, raised $4m in seed funding.
The round was led by Sanofi Ventures and JDRF T1D Fund. In conjunction wi... |
| 09.04.2020 | i2O Therapeutics Raises $4M In Seed Funding | BOSTON--(BUSINESS WIRE)--i2O Therapeutics, an innovative biotech company developing a platform for oral delivery of traditionally injectable biological drugs, announced today it has raised a $4 million seed funding round led by Sanofi Ventu... |
| 09.04.2020 | i2O Therapeutics Nabs $4M Seed Round |
BOSTON, MA, i2O Therapeutics announced today it has raised a $4 million seed funding round.
>> Click here for more funding data on i2O Therapeutics
>> To export i2O Therapeutics funding data to PDF and Excel, click here
i... |
| - | i2o Therapeutics | “i2o Therapeutics is a biotech startup that has developed disruptive ionic liquid technology for oral delivery of biologics.” |
Reviews 0
